Extensive Co-Operation between the Epstein-Barr Virus EBNA3 Proteins in the Manipulation of Host Gene Expression and Epigenetic Chromatin Modification
暂无分享,去创建一个
Robert E. White | E. Kremmer | E. Turro | M. Allday | I. Groves | J. Yee | Ian J. Groves | Jade Yee
[1] Sung-Mi Shim,et al. Expression phenotype changes of EBV‐transformed lymphoblastoid cell lines during long‐term subculture and its clinical significance , 2010, Cell proliferation.
[2] Robert E. White,et al. Epigenetic Repression of p16INK4A by Latent Epstein-Barr Virus Requires the Interaction of EBNA3A and EBNA3C with CtBP , 2010, PLoS pathogens.
[3] R. Sompallae,et al. Three Epstein–Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints , 2009, Oncogene.
[4] S. Pillai,et al. The follicular versus marginal zone B lymphocyte cell fate decision , 2009, Nature Reviews Immunology.
[5] Kristian Helin,et al. Polycomb group proteins: navigators of lineage pathways led astray in cancer , 2009, Nature Reviews Cancer.
[6] Alex Lewin,et al. MMBGX: a method for estimating expression at the isoform level and detecting differential splicing using whole-transcript Affymetrix arrays , 2009, Nucleic acids research.
[7] Robert E. Kingston,et al. Mechanisms of Polycomb gene silencing: knowns and unknowns , 2009, Nature Reviews Molecular Cell Biology.
[8] M. Calderwood,et al. Epstein-Barr Virus Nuclear Protein 3C Domains Necessary for Lymphoblastoid Cell Growth: Interaction with RBP-Jκ Regulates TCL1 , 2009, Journal of Virology.
[9] Sourav Bandyopadhyay,et al. Evolutionarily Conserved Herpesviral Protein Interaction Networks , 2009, PLoS pathogens.
[10] E. Kremmer,et al. Differential Gene Expression Patterns of EBV Infected EBNA-3A Positive and Negative Human B Lymphocytes , 2009, PLoS pathogens.
[11] E. Robertson,et al. Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities. , 2009, Virology.
[12] Robert E. White,et al. Epstein-Barr Virus Latency in B Cells Leads to Epigenetic Repression and CpG Methylation of the Tumour Suppressor Gene Bim , 2009, PLoS pathogens.
[13] B. Blom,et al. New insights into the regulation of human B-cell differentiation. , 2009, Trends in immunology.
[14] E. Robertson,et al. Epstein-Barr Virus Nuclear Antigen 3C Augments Mdm2-Mediated p53 Ubiquitination and Degradation by Deubiquitinating Mdm2 , 2009, Journal of Virology.
[15] D. Thorley-Lawson,et al. The Intersection of Epstein-Barr Virus with the Germinal Center , 2009, Journal of Virology.
[16] D. Thorley-Lawson,et al. The curious case of the tumour virus: 50 years of Burkitt's lymphoma , 2008, Nature Reviews Microbiology.
[17] D. Allman,et al. Transcriptional regulation of early B cell development , 2008, Immunologic research.
[18] H. Spits,et al. T cell–independent development and induction of somatic hypermutation in human IgM+IgD+CD27+ B cells , 2008, The Journal of experimental medicine.
[19] A. De Rossi,et al. Latent Membrane Protein 1 of Epstein-Barr Virus Activates the hTERT Promoter and Enhances Telomerase Activity in B Lymphocytes , 2008, Journal of Virology.
[20] S. Swaminathan. Noncoding RNAs produced by oncogenic human herpesviruses , 2008, Journal of cellular physiology.
[21] W. Lucchesi,et al. Differential Gene Regulation by Epstein-Barr Virus Type 1 and Type 2 EBNA2 , 2008, Journal of Virology.
[22] Robert E. White,et al. Epstein–Barr virus nuclear antigen (EBNA) 3A induces the expression of and interacts with a subset of chaperones and co-chaperones , 2008, The Journal of general virology.
[23] Kyoko Ochiai,et al. Regulation of the plasma cell transcription factor Blimp-1 gene by Bach2 and Bcl6. , 2008, International immunology.
[24] Robert E. White,et al. Two Epstein–Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma , 2008, Oncogene.
[25] B. Stollar,et al. Influence of EBV on the Peripheral Blood Memory B Cell Compartment1 , 2007, The Journal of Immunology.
[26] M. Masucci,et al. Epstein–Barr virus promotes genomic instability in Burkitt's lymphoma , 2007, Oncogene.
[27] A. Vazquez,et al. Epstein–Barr virus and virus human protein interaction maps , 2007, Proceedings of the National Academy of Sciences.
[28] B. Han,et al. Identification of stathmin 1 expression induced by Epstein–Barr virus in human B lymphocytes , 2007, Cell proliferation.
[29] T. Kanda,et al. Epstein–Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells , 2006, Proceedings of the National Academy of Sciences.
[30] E. Kieff,et al. EBNA-3B- and EBNA-3C-Regulated Cellular Genes in Epstein-Barr Virus-Immortalized Lymphoblastoid Cell Lines , 2006, Journal of Virology.
[31] A. Hartmann,et al. Cellular Target Genes of Epstein-Barr Virus Nuclear Antigen 2 , 2006, Journal of Virology.
[32] W. Lucchesi,et al. Cell target genes of Epstein-Barr virus transcription factor EBNA-2: induction of the p55alpha regulatory subunit of PI3-kinase and its role in survival of EREB2.5 cells. , 2006, The Journal of general virology.
[33] James A. Cuff,et al. A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells , 2006, Cell.
[34] T. Sculley,et al. Nuclear localization of the Epstein-Barr virus EBNA3B protein. , 2006, The Journal of general virology.
[35] E. Robertson,et al. Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[36] E. Kieff,et al. Mediation of Epstein–Barr virus EBNA‐LP transcriptional coactivation by Sp100 , 2005, The EMBO journal.
[37] M. Allday,et al. Epstein-Barr virus EBNA3 proteins bind to the C8/alpha7 subunit of the 20S proteasome and are degraded by 20S proteasomes in vitro, but are very stable in latently infected B cells. , 2005, The Journal of general virology.
[38] Xiaoqun Jiang,et al. Epstein-Barr Virus with the Latent Infection Nuclear Antigen 3B Completely Deleted Is Still Competent for B-Cell Growth Transformation In Vitro , 2005, Journal of Virology.
[39] E. Robertson,et al. SCFSkp2 Complex Targeted by Epstein-Barr Virus Essential Nuclear Antigen , 2005, Molecular and Cellular Biology.
[40] E. Robertson,et al. A Cyclin-Binding Motif within the Amino-Terminal Homology Domain of EBNA3C Binds Cyclin A and Modulates Cyclin A-Dependent Kinase Activity in Epstein-Barr Virus-Infected Cells , 2004, Journal of Virology.
[41] L. Young,et al. Epstein–Barr virus: 40 years on , 2004, Nature Reviews Cancer.
[42] X. Deng,et al. Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells. , 2004, Journal of experimental & clinical cancer research : CR.
[43] T. Ide,et al. Steps Involved in Immortalization and Tumorigenesis in Human B-Lymphoblastoid Cell Lines Transformed by Epstein-Barr Virus , 2004, Cancer Research.
[44] D. Thorley-Lawson,et al. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. , 2004, The New England journal of medicine.
[45] E. Robertson,et al. Epstein-Barr Virus Nuclear Antigen 3C Regulates Cyclin A/p27 Complexes and Enhances Cyclin A-Dependent Kinase Activity , 2004, Journal of Virology.
[46] T. Sculley,et al. The Epstein-Barr virus nuclear antigen-6 protein co-localizes with EBNA-3 and survival of motor neurons protein. , 2004, Virology.
[47] Robert E. White,et al. Generation and precise modification of a herpesvirus saimiri bacterial artificial chromosome demonstrates that the terminal repeats are required for both virus production and episomal persistence. , 2003, The Journal of general virology.
[48] L. Young,et al. Epstein–Barr virus and oncogenesis: from latent genes to tumours , 2003, Oncogene.
[49] E. Robertson,et al. Epstein-Barr Virus Nuclear Antigen 3C Recruits Histone Deacetylase Activity and Associates with the Corepressors mSin3A and NCoR in Human B-Cell Lines , 2003, Journal of Virology.
[50] Andrea Califano,et al. Transcriptional analysis of the B cell germinal center reaction , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[51] P. Freemont,et al. Two Nonconsensus Sites in the Epstein-Barr Virus Oncoprotein EBNA3A Cooperate to Bind the Co-repressor Carboxyl-terminal-binding Protein (CtBP)* , 2002, The Journal of Biological Chemistry.
[52] W. Hammerschmidt,et al. Glycoprotein gp110 of Epstein–Barr virus determines viral tropism and efficiency of infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[53] L. Strobl,et al. EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes. , 2001, Seminars in cancer biology.
[54] T. Crook,et al. Physical and Functional Interactions between the Corepressor CtBP and the Epstein-Barr Virus Nuclear Antigen EBNA3C , 2001, Journal of Virology.
[55] D. Crawford,et al. Biology and disease associations of Epstein-Barr virus. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[56] G. Parker,et al. Epstein-Barr virus EBNA3C can disrupt multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis , 2000, Oncogene.
[57] M. Wade,et al. Epstein-Barr Virus Suppresses a G2/M Checkpoint Activated by Genotoxins , 2000, Molecular and Cellular Biology.
[58] T. Kouzarides,et al. Epstein-Barr Virus Nuclear Antigen 3C Interacts with Histone Deacetylase To Repress Transcription , 1999, Journal of Virology.
[59] R. Dalla‐Favera,et al. Direct activation of TERT transcription by c-MYC , 1999, Nature Genetics.
[60] W. Hammerschmidt,et al. Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[61] P. Farrell,et al. Multiple Functions within the Epstein-Barr Virus EBNA-3A Protein , 1998, Journal of Virology.
[62] L. Waltzer,et al. Transcriptional repression by the Epstein-Barr virus EBNA3A protein tethered to DNA does not require RBP-Jkappa. , 1998, The Journal of general virology.
[63] P. Farrell,et al. Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21 , 1997, Journal of virology.
[64] A. Rickinson,et al. Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain , 1997, Journal of virology.
[65] E. Kieff,et al. Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation , 1997, Journal of virology.
[66] T. Crook,et al. Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7. , 1996, Oncogene.
[67] M. Perricaudet,et al. Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA , 1996, Journal of virology.
[68] R. Watson,et al. Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA , 1996, Journal of virology.
[69] C. Sample,et al. Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator , 1995, Journal of virology.
[70] B. Leber,et al. Telomerase activity in normal leukocytes and in hematologic malignancies. , 1995, Blood.
[71] E. Kieff,et al. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa , 1995, Journal of virology.
[72] E. Kremmer,et al. Rat monoclonal antibodies differentiating between the Epstein-Barr virus nuclear antigens 2A (EBNA2A) and 2B (EBNA2B). , 1995, Virology.
[73] M. Perricaudet,et al. The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter. , 1994, Virology.
[74] P. Ling,et al. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. , 1994, Science.
[75] E. Kieff,et al. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation , 1993, Journal of virology.
[76] E. Kieff,et al. Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro , 1992, Journal of virology.
[77] D. Rowe,et al. Size and stability of the Epstein-Barr virus major internal repeat (IR-1) in Burkitt's lymphoma and lymphoblastoid cell lines. , 1989, Virology.
[78] G. Lenoir,et al. Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains , 1988, Journal of virology.
[79] I. Ernberg,et al. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines , 1987, Journal of virology.
[80] J. Banchereau,et al. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[81] L. Young,et al. Differences in B cell growth phenotype reflect novel patterns of Epstein‐Barr virus latent gene expression in Burkitt's lymphoma cells. , 1987, The EMBO journal.
[82] E. Robertson. Epstein-barr virus : latency and transformation , 2010 .
[83] M. Allday,et al. Deregulation of the cell cycle by the Epstein-Barr virus. , 2004, Advances in cancer research.